Webinars
Vaginal Insert Therapies: Increasing Acceptance by Patients and Providers
Archived Sessions:
This is an internet-based activity that should take 1 hour to complete.
To participate in this archived webinar learners should:
- Take the pretest
- Listen to webinar
- Take the post-test
- Complete follow-up evaluation survey
Learning Objectives
At the conclusion of this program, participants should be able to:
- Increase the likelihood that your patients should appropriately select, adhere to, and be satisfied with their vaginal insert therapies
- Discuss vaginal insert therapies when counseling your patients about their contraceptive options
- Discuss vaginal insert therapies when counseling your patients about their options for treatment of vulvovaginal atrophy and menopausal symptoms
- Recognize and address barriers to effective communication, thereby minimizing patient and provider discomfort when discussing vaginal insert therapies
Accreditation Information
Physicians:
ACCREDITATION
The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATION
ARHP designates this internet enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Practitioners and Nurses:
This activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for up to 1.0 contact hour, including up to 0.5 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.
Others:
A certificate of attendance will be issued indicating that this activity is accredited for 1 hour of AMA PRA Category 1 CreditTM.
Sponsoring Information
This program is sponsored by the Association of Reproductive Health Professionals.
Funding Information
This project is funded through an unrestricted educational grant from Merck & Co., Inc.
Disclosure Information
All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.
Advisory Committee Disclosures
| Sheryl A. Kingsberg, PhD
Chief, Division of Behavioral Medicine
University Hospitals Case Medical Center
MacDonald Women’s Hospital
Dr. Kingsberg consultant for Boehringer Ingelheim and Wyeth Pharmaceuticals. She is a speaker for Eli Lilly and Company and Johnson and Johnson.
Anne Katz, RN, PhD
Clinical Nurse Specialist
CancerCare Manitoba
Dr. Katz has nothing to disclose. |
Susan Goodman, MD, MPH
Associate Clinical Professor
Department of Family and Community Medicine
University of California San Francisco
Dr. Goodman has nothing to disclose. |
ARHP Staff/Consultant Disclosures
|
Ellen L. Cohen, CertEd, DipEd
Director of Education
Nothing to disclose
Camille V. Harris, MPH
Program Manager
Nothing to Disclose |
Beth Jordan, MD
Medical Director
Nothing to disclose
Wayne Shields
President and CEO
Nothing to disclose |
Back
|
